Senti Biosciences is trading 12.46% up at $0.35 in after-hours trading amid an unclear company-specific catalyst on September 16, 2026.

  • Earlier in September, disclosures covered a $2.5 million equity commitment, proposed merger, contingent value rights, and additional convertible-note financing.
  • No new event directly explains the after-hours move.
  • Broader markets were mixed, offering limited support for attributing the gain to macro sentiment.